Development of pulmonary arterial hypertension in a patient treated with qing-dai (Chinese herbal medicine)

Kayo Misumi; Takeshi Ogo; Jin Ueda; Akihiro Tsuji; Sigefumi Fukui; Nao Konagai; Ryotaro Asano; Satoshi Yasuda

doi:10.2169/internalmedicine.1523-18

Development of pulmonary arterial hypertension in a patient treated with qing-dai (Chinese herbal medicine)

Kayo Misumi, Takeshi Ogo, Jin Ueda, Akihiro Tsuji, Sigefumi Fukui, Nao Konagai, Ryotaro Asano, Satoshi Yasuda

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Abstract

Pulmonary arterial hypertension (PAH) is a rare, devastating disease, characterized by elevated pulmonary arterial pressure due to pulmonary microvascular obstruction, which can result in heart failure and death. PAH can be associated with exposure to certain drugs or toxins. We herein report a case in which PAH developed in a patient with refractory ulcerative colitis during treatment with “Qing-Dai,” a Chinese herbal medicine. The patient’s PAH improved after the discontinuation of Qing-Dai.

Original language	English
Pages (from-to)	395-399
Number of pages	5
Journal	Internal Medicine
Volume	58
Issue number	3
DOIs	https://doi.org/10.2169/internalmedicine.1523-18
Publication status	Published - 2019
Externally published	Yes

All Science Journal Classification (ASJC) codes

Internal Medicine

Access to Document

10.2169/internalmedicine.1523-18

Cite this

@article{411ca57519b041d289998494f3dbefe5,

title = "Development of pulmonary arterial hypertension in a patient treated with qing-dai (Chinese herbal medicine)",

abstract = "Pulmonary arterial hypertension (PAH) is a rare, devastating disease, characterized by elevated pulmonary arterial pressure due to pulmonary microvascular obstruction, which can result in heart failure and death. PAH can be associated with exposure to certain drugs or toxins. We herein report a case in which PAH developed in a patient with refractory ulcerative colitis during treatment with “Qing-Dai,” a Chinese herbal medicine. The patient{\textquoteright}s PAH improved after the discontinuation of Qing-Dai.",

author = "Kayo Misumi and Takeshi Ogo and Jin Ueda and Akihiro Tsuji and Sigefumi Fukui and Nao Konagai and Ryotaro Asano and Satoshi Yasuda",

note = "Publisher Copyright: {\textcopyright} 2019 The Japanese Society of Internal Medicine.",

year = "2019",

doi = "10.2169/internalmedicine.1523-18",

language = "English",

volume = "58",

pages = "395--399",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "3",

}

TY - JOUR

T1 - Development of pulmonary arterial hypertension in a patient treated with qing-dai (Chinese herbal medicine)

AU - Misumi, Kayo

AU - Ogo, Takeshi

AU - Ueda, Jin

AU - Tsuji, Akihiro

AU - Fukui, Sigefumi

AU - Konagai, Nao

AU - Asano, Ryotaro

AU - Yasuda, Satoshi

PY - 2019

Y1 - 2019

N2 - Pulmonary arterial hypertension (PAH) is a rare, devastating disease, characterized by elevated pulmonary arterial pressure due to pulmonary microvascular obstruction, which can result in heart failure and death. PAH can be associated with exposure to certain drugs or toxins. We herein report a case in which PAH developed in a patient with refractory ulcerative colitis during treatment with “Qing-Dai,” a Chinese herbal medicine. The patient’s PAH improved after the discontinuation of Qing-Dai.

AB - Pulmonary arterial hypertension (PAH) is a rare, devastating disease, characterized by elevated pulmonary arterial pressure due to pulmonary microvascular obstruction, which can result in heart failure and death. PAH can be associated with exposure to certain drugs or toxins. We herein report a case in which PAH developed in a patient with refractory ulcerative colitis during treatment with “Qing-Dai,” a Chinese herbal medicine. The patient’s PAH improved after the discontinuation of Qing-Dai.

UR - http://www.scopus.com/inward/record.url?scp=85061061521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061061521&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.1523-18

DO - 10.2169/internalmedicine.1523-18

M3 - Article

C2 - 30210129

AN - SCOPUS:85061061521

SN - 0918-2918

VL - 58

SP - 395

EP - 399

JO - Internal Medicine

JF - Internal Medicine

IS - 3

ER -

Development of pulmonary arterial hypertension in a patient treated with qing-dai (Chinese herbal medicine)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this